Researchers raise questions on rapid tests' accuracy early in COVID-19 infection; data show dementia prevalence could triple by 2050; COVID-19 vaccines could lead to minor, temporary changes in menstruation cycles.
Two new articles published in STAT News discuss some potential pitfalls of using rapid tests to detect the Omicron variant of COVID-19. The first piece discusses findings of a small, not yet peer-reviewed study, that showed the tests were better at detecting COVID-19 several days after infection as opposed to earlier. Although conducted with only 30 participants, the researchers found the rapid antigen tests yielded false negatives early on, even though polymerase chain reaction tests detected high levels of the disease in most individuals. In the second piece, experts stress the importance of using rapid tests, but noted they may be unreliable in some situations.
New research published in The Lancet Public Health estimates the worldwide prevalence of individuals with dementia will increase from 57.4 million in 2019 to 152.8 million in 2050. More women were estimated to have dementia in 2019, and researchers expect this trend to continue in the future. The smallest percent changes were found in high-income Asian Pacific countries and Western Europe. However, regions including North Africa, the Middle East, and eastern Sub-Saharan Africa are projected to have the largest percentage changes. Investigators conclude interventions to address modifiable risk factors and investing in research on biological mechanisms are needed to help meet this growing public health challenge.
A recent study published in Obstetrics and Gynecology found vaccination against COVID-19 could lead to changes in the timing of menstruation, but the changes are temporary and vaccines are still recommended to prevent serious COVID-19 complications, NPR reports. The risks from COVID-19 remain high, and this potential effect is not considered a serious adverse event. In trials testing the now-approved vaccines, aspects of reproductive health, like pregnancy, were prioritized over menstruation, researchers said. Although the exact underlying cause of the relationship is unknown, the investigators point out the immune and reproductive systems are linked.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More